Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/18287
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKlevansky, Myron-
dc.contributor.authorJohn, Thomas-
dc.date.accessioned2018-08-30T04:08:01Z-
dc.date.available2018-08-30T04:08:01Z-
dc.date.issued2018-06-
dc.identifier.citationJournal of thoracic disease 2018; 10(Suppl 17): S1986-S1988-
dc.identifier.issn2072-1439-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/18287-
dc.language.isoeng-
dc.titleCan molecularly targeted therapy cure patients with resected EGFR mutant NSCLC?-
dc.typeJournal Article-
dc.identifier.journaltitleJournal of thoracic disease-
dc.identifier.affiliationOlivia Newton-John Cancer Wellness and Research Centre, Austin Health, Heidelberg, Victoria, Australia-
dc.identifier.affiliationOlivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia-
dc.identifier.doi10.21037/jtd.2018.04.156-
dc.identifier.pubmedid30023098-
dc.type.austinEditorial-
dc.type.austinComment-
local.name.researcherJohn, Thomas
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.languageiso639-1en-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
crisitem.author.deptMedical Oncology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

30
checked on Dec 31, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.